| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 9863 | DOTA-cyclo(RGDfK) acetate |
9863.0001: 1 mg per vial 9863.0010: 10 mg per vial Please inquire for customized filling and bulk quantities. 
|
|
Precursor for radiometal-labelled DOTA-RGD.
|
||
| Molar Mass: 990.1 (net peptide) | ||
| C43H67N13O14 | ||
| [909024-55-1] (net peptide) | ||
| Colourless to off-white freeze-dried solid packaged in screw cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; MS (identity); HPLC (purity) |
||
|
Chemical Name: Sequence: cyclo[-Arg-Gly-Asp-D-Phe-Lys(DOTA)-] |
||
|
Synonymes: DOTA-RGD |
||
|
Literature: Haukkala J. et al. 68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice. Eur. J. Nucl. Med. Mol. Imaging 2009, 36, 2058-2067. |
||
| Decristofero C. et al. 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of ανβ3 integrin expression. Eur. J. Nucl. Med. Mol. Imaging 2008, 35, 1507-1515. | ||
| Yoshimoto M. et al. In Vivo SPECT Imaging with 111In-DOTA-c(RGDfK) to Detect Early Pancreatic Cancer in a Hamster Pancreatic Carcinogenesis Model. J. Nucl. Med. 2012, 53, 765-771. | ||
| date of product catalogue issue: 10 May 2017 | ||